Molupiravir 200mg Capsules, 40 Tab in a bottle, Manufactured by Mylan.
Molnatris 200mg Capsule is the first oral antiviral medication that helps treat mild to moderate COVID-19 in adults. It prevents the virus from multiplying, thereby reducing viral load and disease severity. The drug received emergency use approval from Indian drug regulatory authorities on December 28, 2021.
Molnatris 200mg Capsule is only indicated in patients with mild to moderate COVID-19 symptoms and who have a high risk of developing severe symptoms. The risk factors include obesity, older age (>60 years), diabetes mellitus, and heart diseases. It is not indicated in patients who require immediate hospitalization due to COVID-19. This drug has also been approved by the U.S. Food and Drug Administration (FDA) and the UK regulatory agency for emergency use.
Exports To: Nepal | United States Of America | Afghanistan | Myanmar | Korea
Find products similar to Molnatris Molnupiravir 200mg
Interested in this product?Get Latest Price from the seller
About the Company
GST Registration Date
26-09-2022
Legal Status of Firm
Partnership
Nature of Business
Trader - Wholesaler/Distributor
Number of Employees
11 To 25 People
Annual Turnover
1.5 - 5 Cr
IndiaMART Member Since
Oct 2018
GST
24AAIFO1327Q1ZZ
Import Export Code (IEC)
AAIFO*****
Exports to
Nepal | United States Of America | Afghanistan | Myanmar | Korea
At Oncoheal, we take pride in being a leading pharmaceuticals distributor and believe nothing should stand in the way of what people truly need. That's why we work all over the world, building networks that allow people to access pharmaceuticals where it matters most.
When it's time to make the world a better place, we’re always right there with you.
We cater to the entire spectrum of pharmaceutical trade starting from Wholesale, Tender supplies, Orphan Drugs, Name Patient access, Biologics, Bio-Similars and Vaccines.
We are one of the Pioneers in Comparator drug supplies from India ! Sourcing Drugs from over 60 countries for Clinical trial supplies in India and Internationally.
The primary goal of Oncoheal is to supply our consumers with pharmaceutical products by providing assurance regarding their performance, safety, value and consistency. The commitment to quality is well-rooted in the corporate values of our company and is very essential to our continuous development and success. We strive to meet the comprehensive set of guidelines for distribution of our wide range of pharmaceutical drugs.
